1Life Healthcare Inc. [ONEM] recently increased 0.03% or $0.94 to settle at $30.64. Analysts expect ONEM to grow earnings at a 27.00% annual rate over the next 5 years. ONEM has a short ratio of 4.36. This implies that the market is currently less bullish on the outlook for ONEM.

On 30, September 2020, Houston Methodist and One Medical Announce Partnership Focused on Seamless Coordinated Care. According to news published on Yahoo Finance, One Medical plans to bring its technology-powered primary care model to Houston.

Analyst Birdseye View:

The most recent analyst activity for 1Life Healthcare Inc. [NASDAQ:ONEM] stock was on October 13, 2020, when it was Resumed with a Buy rating from Citigroup, which also raised its 12-month price target on the stock to $38. Before that, on October 14, 2020, Deutsche Bank Recapitulated a Buy rating and elevated its amount target to $37. On July 01, 2020, SVB Leerink Initiated a Mkt perform rating and boosted its price target on this stock to $36. On June 19, 2020, Canaccord Genuity Initiated a Buy rating. On February 25, 2020, William Blair Initiated an Outperform rating. On February 25, 2020, Wells Fargo Initiated an Equal weight rating and boosted its amount on this stock to $24. On February 25, 2020, SunTrust Initiated a Buy rating and boosted its target amount on this stock to $30. Robert W. Baird elevated its amount target by recapitulating a higher weight for this stock.

In the past 52 weeks of trading, this stock has oscillated between a low of $15.00 and a peak of $44.87. Right now, according to Wall Street analyst the average 12-month amount target is $36.20. At the most recent market close, shares of 1Life Healthcare Inc. [NASDAQ:ONEM] were valued at $30.64. According to the average price forecast, investors can expect a potential return of 1.07%.

FUNDAMENTAL ANALYSIS

1Life Healthcare Inc. [NASDAQ:ONEM] most recently reported quarterly sales of 75.6 billion, which represented growth of 14.20%. This publicly-traded organization’s revenue is $162,505 per employee, while its income is -$30,914 per employee. This company’s Gross Margin is currently 35.10%, its Operating Margin is -30.60%, its Pretax Margin is -19.41, and its Net Margin is -19.02. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -13.95, -22.58, -17.54 and -17.84 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 38.80 and the whole liability to whole assets at 31.97. It shows enduring liability to the whole principal at 34.27 and enduring liability to assets at 0.28 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 29.94 points at 1st support level, the second support level is making up to 29.23. But as of 1st resistance point, this stock is sitting at 31.22 and at 31.79 for 2nd resistance point.

1Life Healthcare Inc. [ONEM] reported its earnings at -$0.24 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.33/share signifying the difference of 0.09 and 27.30% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.4 calling estimates for -$0.17/share with the difference of -0.23 depicting the surprise of -135.30%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for 1Life Healthcare Inc. [NASDAQ:ONEM] is 7.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 1.82.

Insider Stories

The most recent insider trade was by Mango Lisa A, General Counsel and Secretary, and it was the sale of 21000.0 shares on Oct 12. Lockhart Kimber D, the Chief Technology Officer, completed a sale of 15000.0 shares on Oct 07. On Sep 28, Rubin Amir Dan, Chair, CEO and President, completed a sale of 0.23 million shares.